NCT01994837 A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML) Status COMPLETED Phase PHASE2
NCT01690507 Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML) Status COMPLETED Phase PHASE1/PHASE2
NCT01570465 Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients Status TERMINATED Phase N/A
NCT01532635 A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives Status TERMINATED Phase PHASE2
NCT01449058 A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01319864 POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients Status COMPLETED Phase PHASE1
NCT01268800 Rapid Profiling of Bone Marrow, at Presentation and After 5 Days of Induction Therapy Status UNKNOWN Phase N/A
NCT01261312 SGI-110 in Participants With Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) Status COMPLETED Phase PHASE1/PHASE2
NCT01204164 Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies Status COMPLETED Phase PHASE1
NCT01188174 Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure Status COMPLETED Phase PHASE2
NCT01184898 Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML) Status COMPLETED Phase NA
NCT01149408 Decitabine Maintenance in Elderly Acute Myeloid Leukemia Patients Status COMPLETED Phase PHASE1
NCT01096602 Blockade of PD-1 in Conjunction With the Dendritic Cell/AML Vaccine Following Chemotherapy Induced Remission Status COMPLETED Phase PHASE2
NCT01019317 Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT01012492 Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT Status COMPLETED Phase PHASE2